Merck Life Science A/S — Credit Rating and Financial Key Figures
CVR number: 20830131
Vandtårnsvej 62 A, 2860 Søborg
lars.ohrberg@sial.com
tel: 43565900
Income statement (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 768.19 | 1 008.60 | 1 256.09 | 1 405.24 | 1 536.25 |
| Other operating income | 0.62 | ||||
| Purchases during the financial year | -1 212.01 | -1 392.59 | |||
| External services | -73.47 | -35.63 | |||
| Gross profit | 72.10 | 69.75 | 80.13 | 119.75 | 108.65 |
| Employee benefit expenses | -26.48 | -23.55 | |||
| Total depreciation | -1.56 | -1.56 | |||
| EBIT | 54.15 | 51.58 | 57.88 | 91.70 | 83.53 |
| Other financial income | 3.64 | 3.41 | |||
| Other financial expenses | -0.69 | -0.87 | |||
| Pre-tax profit | 41.28 | 37.72 | 46.00 | 94.65 | 86.07 |
| Income taxes | -21.04 | -19.34 | |||
| Net earnings | 41.28 | 37.72 | 46.00 | 73.61 | 66.73 |
Assets (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible rights | 1.56 | ||||
| Intangible assets total | 1.56 | ||||
| Advance payments and construction in progress | 0.05 | ||||
| Tangible assets total | 0.05 | ||||
| Investments total | 237.29 | 249.89 | 233.19 | ||
| Long term receivables total | |||||
| Finished products/goods | 2.88 | 18.11 | |||
| Inventories total | 2.88 | 18.11 | |||
| Current trade debtors | 187.41 | 243.85 | |||
| Current amounts owed by group member comp. | 129.40 | 32.26 | |||
| Current other receivables | 1.43 | 1.23 | |||
| Current deferred tax assets | 2.81 | ||||
| Short term receivables total | 318.23 | 280.13 | |||
| Balance sheet total (assets) | 237.29 | 249.89 | 233.19 | 322.68 | 298.30 |
Equity and liabilities (mDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 176.97 | 214.69 | 166.25 | 2.00 | 2.00 |
| Shares repurchased | 90.00 | 70.00 | |||
| Retained earnings | -41.28 | -37.72 | -46.00 | 74.24 | 77.85 |
| Profit of the financial year | 41.28 | 37.72 | 46.00 | 73.61 | 66.73 |
| Shareholders equity total | 176.97 | 214.69 | 166.25 | 239.86 | 216.59 |
| Provisions | 0.19 | ||||
| Non-current deferred tax liabilities | 0.01 | 0.02 | |||
| Non-current liabilities total | 0.01 | 0.02 | |||
| Current loans from credit institutions | 0.01 | 0.15 | |||
| Current trade creditors | 15.26 | 3.39 | |||
| Current owed to group member | 0.00 | 0.00 | |||
| Short-term deferred tax liabilities | 5.57 | ||||
| Other non-interest bearing current liabilities | 39.12 | 49.64 | |||
| Accruals and deferred income | 22.67 | 28.51 | |||
| Current liabilities total | 82.63 | 81.69 | |||
| Balance sheet total (liabilities) | 176.97 | 214.69 | 166.25 | 322.68 | 298.30 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.